- Poster presentation
- Open access
- Published:
Cerebral ischemia-reperfusion model in rabbits: relationship between dexmedetomidine and biochemical parameters in lowering intraparenchymal pressure
Critical Care volume 16, Article number: P328 (2012)
Introduction
The effect of dexmedetomidine in two different doses on the levels of endothelin-1 (ET-1) and prostoglandin I2 (PGI2) in blood and cerebrospinal fluid (CSF) of rabbits via the transient global cerebral ischemia model was studied to determine its intraparenchymal pressure (IPP) reduction mechanism.
Methods
Twenty-four New Zealand type rabbits were employed and randomly distributed into four groups. Group I (sham group, n = 6): craniotomy was performed only. Group II (control group, n = 6): bilateral carotid arteries were clamped for 60 minutes after craniotomy, then reperfusion was performed for 60 minutes. In Group III (n = 6) and Group IV (n = 6), 80 μkg-1 and 320 μkg-1 dexmedetomidine was administered within the first 10 minutes of the reperfusion procedure respectively. Blood and CSF samples were collected 120 minutes after craniotomy. Mean arterial pressures (MAP), heart rates (HR), IPP and temperature values were recorded.
Results
There was no significant difference in MAP values between groups (P ≥ 0.05). A decrease of HR in Group IV was significantly lower after reperfusion (P < 0.05). IPP values after the reperfusion in Groups II and IV were significantly higher than Group I (P < 0.05), but no significant increase in Group III (P ≥ 0.05). ET-1 levels of both blood and CSF were increased in the group with performed ischemia and reperfusion and no treatment (Group II) and the group administered high-dose dexmedetomidine (Group IV) (P < 0.05), while the group administered low-dose dexmedetomidine (Group III) was similar to the sham group (P ≥ 0.05). However, PGI2 levels of CSF were significantly decreased in the group administered low-dose dexmedetomidine (P < 0.05).
Conclusion
References
Zornow MH, Scheller MS, Sheehan PB: Intracranial pressure effects of dexmedetomidine in rabbits. Anesth Analg 1992, 75: 232-237.
Jolkkonen J, Puurunen K, Koistinaho J, et al.: Neuroprotection by the alpha 2-adrenoceptor agonist, dexmedetomidine in rat focal cerebral ischemia. Eur J Pharmacol 1999, 7: 31-36.
Author information
Authors and Affiliations
Rights and permissions
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Tavlan, A., Ustun, M., Yosunkaya, A. et al. Cerebral ischemia-reperfusion model in rabbits: relationship between dexmedetomidine and biochemical parameters in lowering intraparenchymal pressure. Crit Care 16 (Suppl 1), P328 (2012). https://doi.org/10.1186/cc10935
Published:
DOI: https://doi.org/10.1186/cc10935